Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 183 entries
View as:

SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases

Phase: N/A Priority: Normal
NCT ID: NCT05775146 Org: User:
Start: 06/18/24 End: 06/30/28 Due: 06/30/29

A Pilot Study to Evaluate the Feasibility of Combining Submandibular Salivary Gland Tx & IMRT Tomo to Reduce Xerostomia

Phase: N/A Priority: Normal
NCT ID: NCT00497406 Org: User:
Start: 12/31/05 End: 10/31/16 Due: 10/31/17

Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences

Phase: N/A Priority: Normal
NCT ID: NCT01355185 Org: User:
Start: 08/31/11 End: 06/30/15 Due: 06/30/16

Sublingual Methadone for the Management of Cancer Breakthrough Pain

Phase: N/A Priority: Normal
NCT ID: NCT00125294 Org: User:
Start: 09/30/03 End: 01/31/07 Due: 01/31/08

Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01428739 Org: User:
Start: 12/31/07 End: 09/30/14 Due: 09/30/15

Evaluating Taste and Smell Function and Food and Taste Preferences of Head and Neck Cancer Patients During Radiation Therapy/Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00375921 Org: User:
Start: 11/30/06 End: 01/31/11 Due: 01/31/12

Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)

Phase: N/A Priority: Normal
NCT ID: NCT05451043 Org: User:
Start: 07/05/23 End: 10/01/29 Due: 10/01/30

A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours

Phase: N/A Priority: Normal
NCT ID: NCT01876771 Org: User:
Start: 04/29/14 End: 12/31/33 Due: 12/31/34

Prognostic Indicators for Radiation-induced Breast Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT05031065 Org: User:
Start: 01/24/24 End: 05/05/25 Due: 05/05/26

Pilot Trial for Treatment of Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT05432518 Org: User:
Start: 06/27/23 End: 12/01/27 Due: 12/01/28

Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)

Phase: N/A Priority: Normal
NCT ID: NCT05128734 Org: User:
Start: 09/01/25 End: 07/01/28 Due: 07/01/29

An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs

Phase: N/A Priority: Normal
NCT ID: NCT00414570 Org: User:
Start: 11/30/07 End: 02/06/19 Due: 02/06/20

Trial of Combined Radiotherapy and Vertebroplasty for Patients With Painful Metastatic Spinal Lesions

Phase: N/A Priority: Normal
NCT ID: NCT04242589 Org: User:
Start: 03/03/21 End: 11/01/27 Due: 11/01/28

Exercise and Compression for Lymphedema

Phase: N/A Priority: Normal
NCT ID: NCT05022823 Org: User:
Start: 06/29/22 End: 02/08/24 Due: 02/08/25

A Feasibility Study to Compare the Benefits of Endoscopic Tumor Clip Placement and 3T-MRI Simulation for Accurate Target Volume Definition for Rectal Cancer Patients Undergoing Pre-operative Chemoradiation

Phase: N/A Priority: Normal
NCT ID: NCT01133340 Org: User:
Start: 06/30/10 End: 11/30/13 Due: 11/30/14

Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19 in Prostate Cancer Using High Field MRI (3 Tesla), PET, and Biomarkers

Phase: N/A Priority: Normal
NCT ID: NCT00676286 Org: User:
Start: 11/30/08 End: 03/31/16 Due: 03/31/17

A Nutritional Supplement to Support People With Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04175769 Org: User:
Start: 12/19/22 End: 12/31/25 Due: 12/31/26

GEMHDM2014 : Gem-HDM HDT and ASCT for Relapsed/ Refractory Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02295722 Org: User:
Start: 04/30/15 End: 02/28/23 Due: 02/28/24

Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT04461418 Org: User:
Start: 03/30/21 End: 09/23/23 Due: 09/23/24

A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT03469011 Org: User:
Start: 09/18/18 End: 07/31/24 Due: 07/31/25

Studying if Adding Night Compression to Standard Care Will Have Improved Control of Lymphedema in Breast Cancer Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02187289 Org: User:
Start: 10/31/14 End: 11/30/19 Due: 11/30/20

Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)

Phase: N/A Priority: Normal
NCT ID: NCT03391973 Org: User:
Start: 08/24/18 End: 12/30/25 Due: 12/30/26

Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)

Phase: N/A Priority: Normal
NCT ID: NCT05407987 Org: User:
Start: 04/08/25 End: 12/30/26 Due: 12/30/27

Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00703859 Org: User:
Start: 07/31/08 End: - Due: -

Study of Muscle Energy Metabolism in RCC Patients Treated With Sunitinib

Phase: N/A Priority: Normal
NCT ID: NCT02428335 Org: User:
Start: 06/30/15 End: 03/18/19 Due: 03/18/20